Efficacy and Safety of Dapagliflozin as Monotherapy for Type 2 Diabetes Mellitus in Japanese Patients

被引：0
|
作者：
Kaku, Kohei
Inoue, Satoshi
Matsuoka, Osamu
Kiyosue, Arihiro
Azuma, Haruna
Hayashi, Nobuya
Tokudome, Takuto
Langkilde, Anna Maria
Parikh, Shamik
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1014-P
引用
收藏
页码：A260 / A260
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of dapagliflozin treatment for type 2 diabetes mellitus patients with comorbid cardiovascular disease and hypertension
    Cefalu, W.
    Leiter, L.
    De Bruin, T.
    Gause-Nilsson, I.
    Sugg, J.
    Parikh, S.
    DIABETOLOGIA, 2012, 55 : S305 - S305
  • [22] Dapagliflozin in patients with type 2 diabetes mellitus
    Filippatos, Theodosios D.
    Liberopoulos, Evangelos N.
    Elisaf, Moses S.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 29 - 41
  • [23] Efficacy and safety of canagliflozin monotherapy: results from 2 studies in patients with type 2 diabetes mellitus
    Jodar, E.
    Rosenstock, J.
    Chuck, L.
    Gonzalez-Ortiz, M.
    Tong, C.
    Capuano, G.
    Alba, M.
    Qiu, R.
    DIABETOLOGIA, 2015, 58 : S350 - S351
  • [24] Efficacy and safety of teneligliptin in combination with pioglitazone in Japanese patients with type 2 diabetes mellitus
    Kadowaki, Takashi
    Kondo, Kazuoki
    JOURNAL OF DIABETES INVESTIGATION, 2013, 4 (06) : 576 - 584
  • [25] Efficacy and safety of supaglutide monotherapy in patients with type 2 diabetes
    Wang, Q.
    Zhou, Y.
    Li, L.
    Wang, W.
    Tong, G.
    Shi, B.
    Hu, X.
    Bian, F.
    Li, Q.
    Wang, Y.
    Zhao, N.
    Ma, J.
    Li, Y.
    Zhu, D.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S322 - S323
  • [26] Efficacy and safety of evoglipitin monotherapy in patients with type 2 diabetes
    Kim, D.
    Park, J.
    Park, S.
    Lee, M.
    Yoon, K.
    DIABETOLOGIA, 2016, 59 : S357 - S358
  • [27] Efficacy and Safety of Supaglutide Monotherapy in Patients with Type 2 Diabetes
    Wang, Qinghua
    Zhou, Yue
    Wang, Weimin
    Tong, Guoyu
    Jia, Weina
    Li, Liang
    Cheng, Zhifeng
    Lu, Yibing
    Shi, Bimin
    Bian, Fang
    Wang, Yihua
    Shi, Xiaoxia
    Li, Qingju
    Su, Xiuhai
    Wang, Kun
    Yuan, Guoyue
    Li, Liping
    Ling, Hongwei
    Hu, Xiaolin
    Wang, Yangang
    Zhao, Naiqing
    Yang, Yehong
    Ma, Jianhua
    Li, Yiming
    Zhu, Dalong
    DIABETES, 2023, 72
  • [28] Efficacy and safety of dapagliflozin in a dose-ranging monotherapy study of treatment-naive patients with type 2 diabetes
    List, James F.
    Woo, Vincent C.
    Villegas, Enrique Morales
    Tang, Weihua
    Fiedorek, Fred T.
    DIABETES, 2008, 57 : A94 - A94
  • [29] Efficacy and safety of dapagliflozin in a dose-ranging monotherapy study of treatment-naive patients with type 2 diabetes
    List, J. F.
    Woo, V.
    Morales, E.
    Tang, W.
    Fiedorek, F. T.
    DIABETOLOGIA, 2008, 51 : S22 - S23
  • [30] Two-year efficacy and safety of dapagliflozin for patients with type 2 diabetes mellitus and a history of cardiovascular disease
    Gause-Nilsson, I.
    DeBruin, T. W.
    Sugg, J.
    Parikh, S. J.
    Johnsson, E.
    Leiter, L. A.
    DIABETOLOGIA, 2014, 57 : S325 - S325
12345